X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
male (11) 11
natriuretic peptides (10) 10
female (9) 9
cardiovascular (8) 8
heart failure (8) 8
index medicus (7) 7
article (6) 6
internal medicine (6) 6
middle aged (6) 6
aged (4) 4
cardiology (4) 4
cardiology and cardiovascular medicine (4) 4
congestive-heart-failure (4) 4
heart failure - drug therapy (4) 4
natriuretic peptide, brain - blood (4) 4
physiology (4) 4
abridged index medicus (3) 3
animals (3) 3
biomarker (3) 3
cardiac & cardiovascular systems (3) 3
cardiovascular diseases (3) 3
cardiovascular system (3) 3
gene-expression (3) 3
health aspects (3) 3
heart failure - blood (3) 3
heart failure - physiopathology (3) 3
heart failure - therapy (3) 3
kidney - metabolism (3) 3
kidney - physiopathology (3) 3
natriuretic peptide, brain - metabolism (3) 3
physiological aspects (3) 3
population (3) 3
probnp (3) 3
prognosis (3) 3
adult (2) 2
aldosterone (2) 2
antidiuretic hormone receptor antagonists (2) 2
atrial natriuretic factor - blood (2) 2
atrial-natriuretic-peptide (2) 2
blood pressure (2) 2
blood-pressure (2) 2
bnp (2) 2
body mass index (2) 2
cardiac surgery (2) 2
cardiovascular disease (2) 2
chronic disease (2) 2
circulatory and respiratory physiology (2) 2
congestive heart failure (2) 2
cyclic gmp - metabolism (2) 2
development and progression (2) 2
diagnosis (2) 2
disease models, animal (2) 2
diuresis - drug effects (2) 2
diuretics - therapeutic use (2) 2
dogs (2) 2
drug therapy, combination (2) 2
genetic aspects (2) 2
genotype (2) 2
glomerular filtration rate (2) 2
heart failure - diagnosis (2) 2
heart failure - metabolism (2) 2
hormones, hormone substitutes, and hormone antagonists (2) 2
human activities (2) 2
hypertension (2) 2
immunohistochemistry (2) 2
kidney - drug effects (2) 2
kidney diseases (2) 2
kidney function tests (2) 2
left-ventricular dysfunction (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
mortality (2) 2
natriuretic peptide (2) 2
natriuretic peptide, brain - genetics (2) 2
natriuretic peptide, c-type - metabolism (2) 2
natriuretic peptides - metabolism (2) 2
nt-probnp (2) 2
peptides (2) 2
placebos (2) 2
plasma (2) 2
receptor (2) 2
receptor antagonist (2) 2
research (2) 2
rodents (2) 2
sensitivity and specificity (2) 2
severity of illness index (2) 2
studies (2) 2
time factors (2) 2
treatment outcome (2) 2
urology & nephrology (2) 2
vascular surgery (2) 2
water-electrolyte balance - drug effects (2) 2
ace-inhibition (1) 1
activator (1) 1
acute disease (1) 1
adenosine (1) 1
adiponectin (1) 1
age (1) 1
aldosterone - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 16, pp. 1558 - 1565
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 6, pp. 629 - 636
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 9, pp. 904 - 906
Journal Article
Heart Failure Clinics, ISSN 1551-7136, 10/2009, Volume 5, Issue 4, pp. 501 - 514
Circulating levels of the BNP system can help in the diagnosis of cardiovascular disease and provide prognostic information not only for patients who have HF... 
Heart failure | Biomarker | Prognosis | Diagnosis | Natriuretic peptides | Heart Failure - therapy | Natriuretic Peptides - physiology | Time Factors | Natriuretic Peptides - blood | Humans | Heart Failure - diagnosis | Biomarkers - blood | Heart Failure - blood | Natriuretic Peptide, Brain - physiology | Chronic Disease | Natriuretic Peptide, Brain - blood
Journal Article
JACC: Heart Failure, ISSN 2213-1779, 06/2013, Volume 1, Issue 3, pp. 207 - 212
Using a novel, specific assay for proBNP , this study tested the hypotheses that proBNP is secreted by both nonfailing and failing human hearts and that proBNP... 
heart failure | natriuretic peptides | proBNP1-108 | biomarker | Heart failure | Biomarker | ProBNP | Natriuretic peptides | Natriuretic Peptide, Brain - secretion | Humans | Middle Aged | Peptide Fragments - blood | Peptide Fragments - secretion | Female | Male | Aged | Heart Failure - blood | Natriuretic Peptide, Brain - blood
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 12, pp. 1386 - 1395
Objectives The purpose of this study was to investigate circulating pro–B-type natriuretic peptide (proBNP1–108 ) in the general community and evaluate its... 
Cardiovascular | Internal Medicine | heart failure | natriuretic peptide | NT-proBNP | biomarker | BNP | proBNP
Journal Article
Journal Article
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 2, pp. 102 - 109
Journal Article
Journal Article
Journal Article
Circulation Research, ISSN 0009-7330, 12/2002, Volume 91, Issue 12, p. 1127
  Cardiac fibroblasts (CFs) produce extracellular matrix proteins and participate in the remodeling of the heart. It is unknown if brain natriuretic peptide... 
Journal Article
Circulation Research, ISSN 0009-7330, 02/2002, Volume 90, Issue 2, p. 128
  Cardiotrophin-1 (CT-1), a member of the interleukin-6 superfamily, and endothelin-1 (ET-1) are potent hypertrophic factors in cardiomyocytes. Although CT-1... 
Journal Article
Journal of Interventional Cardiology, ISSN 0896-4327, 10/2004, Volume 17, Issue 5, pp. 301 - 306
Despite the introduction of coronary stents and effective anticoagulation regimens, the treatment of ostial lesions is limited by high restenosis rates.... 
Journal Article
Cardiovascular Drug Reviews, ISSN 0897-5957, 2007, Volume 25, Issue 1, pp. 30 - 45
ABSTRACT The nitric oxide (NO)–soluble guanylate cyclase (sGC)‐cyclic 3′,5′‐guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular... 
Blood vessels | Endothelial dysfunction | BAY 58‐2667 | BAY 41‐2272 | Cyclic guanosine monophoshate | Soluble guanylate cyclase | BAY 41-2272 | BAY 58-2667 | NO | PULMONARY-HYPERTENSION | blood vessels | cyclic guanosine monophoshate | MECHANISMS | endothelial dysfunction | soluble guanylate cyclase | ENDOTHELIAL FUNCTION | RECIPROCAL REGULATION | HEART | ACTIVATOR | HEME | BAY-41-2272 | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | Enzyme Activators - pharmacology | Antihypertensive Agents - pharmacology | Pyrazoles - therapeutic use | Heme - metabolism | Vasodilator Agents - therapeutic use | Enzyme Activators - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Endothelium, Vascular - drug effects | Hypertension - drug therapy | Inflammation - metabolism | Inflammation - drug therapy | Hypertension, Pulmonary - drug therapy | Platelet Aggregation - drug effects | Disease Models, Animal | Pyrazoles - pharmacology | Pyridines - therapeutic use | Cardiovascular Diseases - physiopathology | Vasodilator Agents - pharmacology | Cardiovascular Diseases - metabolism | Endothelium, Vascular - physiopathology | Guanylate Cyclase - metabolism | Soluble Guanylyl Cyclase | Heart Failure - metabolism | Hypertension, Pulmonary - metabolism | Antihypertensive Agents - therapeutic use | Cell Adhesion - drug effects | Enzyme Activation - drug effects | Heart Failure - drug therapy | Hypertension - metabolism | Animals | Cyclic GMP - metabolism | Endothelium, Vascular - metabolism | Benzoates - pharmacology | Leukocytes - drug effects | Pyridines - pharmacology | Nitric Oxide - metabolism | Receptors, Cytoplasmic and Nuclear - metabolism | Cardiovascular diseases
Journal Article